Tirzepatide 50mg
Synthetic dual receptor peptide
Research material. Not for human or animal consumption.
Research overview
Tirzepatide 50mg is a lyophilised research peptide supplied in a single vial. Tirzepatide is a synthetic 39-amino-acid peptide (molecular weight approximately 4813 g/mol) that acts on two receptors, GIP and GLP-1, which are involved in blood sugar regulation and appetite. It carries a C20 fatty diacid chain that binds to albumin and extends its half-life. Tirzepatide has been studied extensively in large Phase 3 clinical trials and is the active ingredient in licensed prescription medicines for type 2 diabetes and weight management. This product is not a licensed medicine and is supplied as a research compound only. Store at -20°C away from light, and refrigerate at 2 to 8°C after reconstitution. For research use only. Not for human consumption. Not intended to treat, cure or prevent any disease.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
Questions about Tirzepatide 50mg
PRODUCT QUESTIONSWhat is Tirzepatide 50mg?
Tirzepatide 50mg is a lyophilised synthetic 39 amino acid peptide supplied in a single vial, with a molecular weight of approximately 4813 g/mol. It acts on GIP and glucagon like peptide 1 receptors and carries a C20 fatty diacid chain that binds to albumin and extends its half life.
What research has been published on Tirzepatide 50mg?
Tirzepatide 50mg contains a peptide studied extensively in large Phase 3 clinical trials. Tirzepatide is the active ingredient in licensed prescription medicines for type 2 diabetes and weight management. This product is not a licensed medicine and is supplied as a research compound only.
What batch documentation should accompany Tirzepatide 50mg?
Tirzepatide 50mg: Ask for the COA and analytical reports for the batch being quoted. Tirzepatide carries a C20 fatty diacid side chain and two aminoisobutyric acid residues, so ask for intact mass confirming the side chain, HPLC purity that separates the unacylated peptide, and peptide content for the 50mg vial.
How should Tirzepatide 50mg storage conditions be assessed?
Store Tirzepatide 50mg at −20°C away from light, and refrigerate at 2°C to 8°C after reconstitution. Its fatty acid chain makes it self associate in solution, so mix by gentle swirling rather than shaking.
Request a quotation
Enquire about Tirzepatide 50mg and the documentation for the available batch.
Request a quotation